In this review, we aim to explore the roles of adropin in metabolic syndrome, cerebrovascular and cardiovascular diseases, as well as our recent work demonstrating adropin’s role in subarachnoid hemorrhage-mediated neural injury and delayed cerebral infarction. Here, ENHO is linked to metabolic syndrome.